A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance
NCT ID: NCT07186595
Last Updated: 2025-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
94 participants
INTERVENTIONAL
2025-09-25
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Open-Label JUVÉDERM
Participants will receive at least 2 JUVÉDERM products for at least 3 indications (specific products and indications will be at the discretion of the investigator and per participant eligibility criteria) at Treatment Visit 1.
JUVÉDERM VOLUX XC
Injections
JUVÉDERM VOLUMA XC
Injections
JUVÉDERM VOLBELLA XC
Injections
JUVÉDERM VOLLURE XC
Injections
SKINVIVE by JUVÉDERM
Injections
JUVÉDERM ULTRA XC
Injections
JUVÉDERM ULTRA PLUS XC
Injections
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
JUVÉDERM VOLUX XC
Injections
JUVÉDERM VOLUMA XC
Injections
JUVÉDERM VOLBELLA XC
Injections
JUVÉDERM VOLLURE XC
Injections
SKINVIVE by JUVÉDERM
Injections
JUVÉDERM ULTRA XC
Injections
JUVÉDERM ULTRA PLUS XC
Injections
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimal, moderate, or severe on Allergan Temple Hollowing Scale (ATHS)
* Moderate or severe for both eyes on Allergan Infraorbital Hollow Scale (AIHS)
* Moderate or severe on Allergan Cheek Smoothness Scale (ACSS)
* Moderate, significant, or severe on Mid-face Volume Deficit Scale (MFVDS)
* Moderate or severe on Nasolabial Fold Severity Scale (NLFSS)
* Minimal, mild, or moderate on Allergan Lip Fullness Scale 2 (ALFS2)
* Moderate or severe on Allergan Chin Retrusion Scale (ACRS)
* Moderate or severe on Allergan Loss of Jawline Definition Scale (ALJDS)
* Must be in good health as determined by subject's medical history, physical examination, and vital sign measurements.
Exclusion Criteria
* Excessively loose skin in the face and/or neck.
* Tendency to develop hypertrophic scarring and/or keloid scarring.
22 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AbbVie
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
ABBVIE INC.
Role: STUDY_DIRECTOR
AbbVie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kian Aesthetic Institute /ID# 277045
Los Angeles, California, United States
Pacific Clinical Innovations /ID# 277026
Vista, California, United States
Skin Research Institute LLC /ID# 277038
Coral Gables, Florida, United States
Monarch Plastic Surgery and Skin Renewal Center /ID# 278182
Atlanta, Georgia, United States
SkinDC /ID# 277062
Arlington, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M25-631
Identifier Type: -
Identifier Source: org_study_id